Navigation Links
Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data
Date:5/9/2008

security needs evolve."

The use of biometric ePassports will enable the Taiwanese government to protect the integrity and verify the authenticity of data stored on the MRTDs, as well as help stop the use of forged or tampered travel documents. Initial ePassport projects typically standardize on BAC, which features passive and optional active authentication and is in production in Europe and many parts of the world. Entrust provides BAC ePassport security for a number of top global e-governments, including the U.S., U.K., Slovenia, Singapore, New Zealand and now Taiwan.

A vital tool to help protect both international and domestic borders, ePassport travel documents contain an electronic chip -- smart card or RFID -- that stores information that can be verified against the data on the passport as well as against the individual. Because of the sensitivity of this personal information (e.g., digitized photographs, or other biometrics) the security and integrity of ePassports are critical. To protect these assets, PKI is an integral technology for the security and verification infrastructure of ePassports.

Modular and fully integrated, the Entrust Authority PKI portfolio is built on the foundation of Entrust Authority Security Manager, the certification authority (CA) system responsible for issuing and managing users' digital identities. Optional components help organizations manage the entire lifecycle of PKI certificates. Approximately 1,000 government and commercial organizations have purchased Entrust PKI solutions since Entrust introduced its first PKI.

Also available from Entrust Authority Security Manager, Extended Access Control (EAC) provides a higher level of security during the verification process of ePassports. To experience the benefits of the next-generation ePassports, visit the Entrust interactive EAC demonstration at https://www.entrust.com/forms/eac-de
'/>"/>

SOURCE Entrust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Stanford/Packard researchers find disease genes hidden in discarded data
2. Facial attraction -- choice of sexual partner shaped the human face
3. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
4. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
5. UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections
6. Conservation International and Toyota partner to protect Philippines rain forests
7. Institution of Chemical Engineers chooses Elsevier as publishing partner
8. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
9. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
10. New partnership offers outsourced R&D in membrane biology
11. M2SYS Technology Partners with TeraCorp Enterprises to Provide Added Security Within Check Cashing Solution

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ersity of Oklahoma researchers were sequencing the...e project. Today, the OU Advanced Center for Gen... effort to sequence the tomato genome with a $7.5 ...dation for plant genomics. , "The tomato has tr...tomato and crop yields will improve quality of lif...
(Date:11/20/2009)...coal-tar-based sealcoats in parking lots may be th... a USGS study. PAHs or polycyclic aromatic hydro...d tar deposits, and can have toxic effects. It,s l...dust; however, the specific sources of these PAHs ...ust from indoor areas near parking lots with coal-...
(Date:11/20/2009)... disease (COPD), a respiratory disease commonly kn...rth leading cause of death worldwide. 600 million...yet to find any real treatment or cure, Grace Parr...y of Western Ontario in London, Canada, is using v... the disease. , Parraga is a scientist in th...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 1Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 3Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 4Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 5Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 6Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 1Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 2Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 3Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 4The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 1The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 2The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 3The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 4
...e Canadian government regulatory agency, has appro...he most popular cold/flu remedy in Canada. After ...irectorate (NHPD) ?a division of Health Canada res...uality of natural health products (NHPs) ?has issu...l to the public with specific science backed claim...
...mericans have hypertension, that is, blood pressur...80 mmHg). If untreated, it can lead to heart atta... are the first-stage treatment for the disease, bu...Many patients with high blood pressure have sought...e (CAM). In so doing, many have consumed danshen, ...
...ark Kay, MD, PhD, published the first results sho...rference could be an effective gene therapy techni...effectively shut down the viruses that cause hepa...e therapy trials now under way - two in macular d...ue Kay pioneered may be among the first to find w...
Other Biology News:Health Canada approves cold and flu medicine 2Active ingredient in common Chinese herb shown to reduce hypertension 2RNAi shows promise in gene therapy, Stanford researcher says 2
(Date:11/20/2009)...ov. 20 Veridiam (www.veridiam.com)... company category at the 2009 Workplace Excellence... Society for Human Resources Management and recogn...ctices. ,, Veridiam was one of nine winners, se...nies, honored at the recent awards ceremony. San D...
(Date:11/20/2009)... Md., Nov. 20 Novavax, I...riced an underwritten public offering of 6,800,000...ic of $3.30 per share. The approximately $21 mill...ing discounts and commissions, will be used for pr...ased vaccines, internal research and development p...
(Date:11/20/2009)... Nov. 20 Cell Therapeuti...day that the Ninth Circuit Court of Appeals revers...should be allowed to pursue all of its claims agai...istrict Court for trial. CTI filed a complaint ag...mbursement consultant for CTI,s product TRISENOX, ...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domi...;The Role of Process Analytical Technology (PAT) i...December 1, 2009. , (PRWE...ocess Analytical Technology (PAT) in Green Chemist...rocess Analytical Technology (PAT) case studies wi...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...08 and Full Year 2009 Earnings Guidance , , ... ) today announced further actions to address curr... competitiveness in 2009, including continued focu...uidance for the fourth quarter 2008 and the full y...ruction and motor vehicle sales and consumer spend...
... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM )...l results for the second quarter of fiscal year 20...host a conference call and webcast to discuss the ... Peregrine,s senior management will discuss fina... 31, 2008 and will review recent operating highlig...
... Inc. (Nasdaq: DCTH ) today announced that Jonat...position as a director of the Company, effective D...at his decision to leave the Delcath board is a re...ositions. , , (Logo: http://www.newscom.com...Harold Koplewicz, Chairman of the Board of Directo...
Other Biology Technology:DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2
Mouse Anti-Human BTG2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Attofluor cell chamber from Molecular Probes (Invitrogen)
...ate double-stranded DNA (dsDNA) in solution, even ...DNA is stained with Hoechst 33258 dye, which can b... The kit quantitates dsDNA in the range of 10 ng p...33258, calf thymus DNA standard, and assay buffer ...
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
Biology Products: